Here are recent angel and venture finance transactions for science- and engineering-based companies, as reported by Xconomy and elsewhere.
Biomedical/Life Sciences
Rosetta Genomics Ltd. in Philadelphia, Pennsylvania. MicroRNA-based molecular diagnostics. $6.0 million, equity.
Versartis in Mountain View, California. Protein drugs for endocrine disorders. $21 million in Series B equity financing.
Ivivi Health Sciences in San Francisco, California. Devices for reducing post-operative pain and swelling. $4 million in new capital and conversion of a $5.5 million bridge loan into an equity stake.
CalciMedica in San Diego, California. Biotechnology, drugs for psoriasis. $6 million in venture financing.
Conatus Pharmaceuticals in San Diego, California. Drugs for liver disease and cancers. $20 million, equity.
Marina Biotech in Bothell, Washington. $5.1 million in a stock offering.
Energy and Environment
Ze-Gen, in Boston, Massachusetts. Technology for converting solid waste into gas for power plants. $8 million, equity.
Calisolar in Sunnyvale, California. Technology for purifying silicon in solar cells. $8 million in debt, options, and securities.
Brightsource Energy in Oakland, California. Solar thermal plant in the Mojave Desert. $89.55 million in new equity financing.
Engineering and Electronics
EcoATM in San Diego, California. Automated kiosks for recycling cell phones and other devices. $14.4 million in preferred equity and venture debt financing.
Read more, Finance Friday: 11 February 2011
* * *
You must be logged in to post a comment.